May 14, 2024 · Form 4 insider transaction
Doyle Anthony bought 36,300 shares of BioCryst Pharmaceuticals, Inc. at $5.57 per share, a transaction worth $202.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.